Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan

计划入组 312 人 · 首次发布于 2024 年 7 月 17 日

Radiotherapy for Prostate and Oligo-metastatic Lesions in Patients With Low-burden Oligo-metastatic Prostate Cancer

计划入组 30 人 · 首次发布于 2024 年 1 月 10 日

Prediction of True Oligo-metastatic Disease.

计划入组 32 人 · 首次发布于 2023 年 4 月 10 日

Oligo-G

MDK Oligo (Roquefort Therapeutics)

Oligo-nucleotide against Pro-opiomelanocortin

ALTEOGEN Inc.

South Korea

ADC Therapeutics

Switzerland

Avidity Biosciences

United States

NJ Bio and Ajinomoto Bio-Pharma Services Partner to Advance Antibody-Drug Conjugate Development Through AJICAP™ Platform Integration

Oligo Factory Expands Capabilities with New Low-Scale Synthesis Platform for Therapeutic and Diagnostic Development

Error parsing response